Scythian logo.jpg
Scythian Biosciences Announces Name Change to SOL Global Investments Corp.
October 25, 2018 08:30 ET | Scythian Biosciences Corp.
TORONTO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Company has changed its...
Scythian logo.jpg
Scythian Biosciences Makes Strategic Investment in Verano™ Holdings with $188 Million USD Transaction
October 23, 2018 07:00 ET | Scythian Biosciences Corp.
Scythian Invests USD$88 Million in Verano Class B Membership Units Scythian to Sell 3 Boys Farms in Share Exchange for USD$100 Million in Verano Class B Membership Units M&A Identified, Talent...
Scythian logo.jpg
Scythian Biosciences Applauds the UK Government’s Decision to Legalize Medical Cannabis
October 12, 2018 08:15 ET | Scythian Biosciences Corp.
Scythian’s Chief Medical Officer, The Famed Dr. Barnes, Receives National Praise for His Advocacy, Education and Tireless Leadership from Government, Media and Medical Organizations to Assist in...
Scythian logo.jpg
Scythian Biosciences Announces Major Milestone in U.S. Expansion
October 11, 2018 08:15 ET | Scythian Biosciences Corp.
Florida Department of Health Approves CannCure’s Purchase of 60% of the Equity of 3 Boys Farms Including the License to Operate as a Medical Marijuana Treatment Center in Florida 3 Boys Farms Gets...
Scythian logo.jpg
Scythian Biosciences Appoints Brady Cobb as CEO
October 03, 2018 08:41 ET | Scythian Biosciences Corp.
TORONTO, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) announced today Brady Cobb, a leading voice...
Scythian logo.jpg
Scythian Biosciences Announces Intention to Commence Normal Course Issuer Bid to Repurchase up to 5% of its Common Shares
October 01, 2018 08:00 ET | Scythian Biosciences Corp.
TORONTO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (“Scythian” or the “Company”) (CSE:SCYB) (Frankfurt: 9SB) (OTC – Nasdaq Intl: SCCYF) announced its intention to commence a...
Scythian logo.jpg
Scythian Biosciences Appoints Peter Liabotis as CFO
September 28, 2018 08:32 ET | Scythian Biosciences Corp.
TORONTO, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Peter Liabotis, a veteran senior corporate finance executive and certified public accountant, has been appointed Chief Financial Officer of Scythian...
Scythian logo.jpg
Scythian Biosciences Closes Strategic Sale of Latin American and Caribbean Assets
September 27, 2018 12:02 ET | Scythian Biosciences Corp.
Scythian Received 15,678,310 common shares of Aphria Inc. as Consideration for the Sale Scythian’s Current Number of Issued and Outstanding Common Shares is 48,849,218 TORONTO, Sept. 27, 2018 ...
Scythian logo.jpg
Scythian Biosciences Closes Acquisition of MMJ International Investments Inc.
September 21, 2018 08:00 ET | Scythian Biosciences Corp.
Closing of Argentine Acquisition is Key Benchmark in Finalization of Previously Announced $193 Million Sale of Assets in Latin America, Which as of Prior Day Close was Valued At Approximately $313...
Scythian logo.jpg
Scythian Biosciences Announces Successful Results of Special Meeting of Shareholders
September 17, 2018 08:00 ET | Scythian Biosciences Corp.
Shareholders Approve Strategic Sale of Latin American Assets to Aphria in Exchange for 15,678,310 shares of Aphria (TSX:APH) Shareholders Approve Name Change to SOL Investments Corp. Scythian’s...